batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. ASCO-GI – Braftovi shoots for a survival benefit 27 January 2025 ASCO-GI – Exelixis opens up its Cabinet again 27 January 2025 A curate's egg for Merck/Eisai's Leap 24 January 2025 ASCO-GI – Inhibrx presses ahead with DR5 23 January 2025 ASCO-GI – casdozokitug responses deepen 22 January 2025 ArriVent ups its ADC bet 22 January 2025 Astra and Daiichi finally get their Datroway 20 January 2025 Evopoint doesn't follow Pfizer into prostate cancer 17 January 2025 Load More